Lersivirine(UK 453061)
- CAS No.
- 473921-12-9
- Chemical Name:
- Lersivirine(UK 453061)
- Synonyms
- CS-628;UK 453061;UK 453061; UK453061;Lersivirine(UK 453061);5-((3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl)oxy)isophthalonitrile;3-Cyano-5-[[3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl]oxy]benzonitrile;5-[3,5-DIETHYL-1-(2-HYDROXYETHYL)PYRAZOL-4-YL]OXYBENZENE-1,3-DICARBONITRILE;1,3-Benzenedicarbonitrile, 5-[[3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl]oxy]-;HIV,non-nucleoside reverse transcription,Reverse Transcriptase,HIV virus,UK 453061,Inhibitor,Lersivirine,UK453061,Human immunodeficiency virus,inhibit,resistant strain,NNRTI,NNRTI-resistant
- CBNumber:
- CB62484893
- Molecular Formula:
- C17H18N4O2
- Molecular Weight:
- 310.35
- MDL Number:
- MFCD16619314
- MOL File:
- 473921-12-9.mol
- MSDS File:
- SDS
Boiling point | 455.4±45.0 °C(Predicted) |
---|---|
Density | 1.19 |
storage temp. | Store at -20°C |
solubility | Soluble in DMSO |
form | Powder |
pka | 14.34±0.10(Predicted) |
FDA UNII | R3ZGC15A9A |
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS07 |
---|---|
Signal word | Warning |
Hazard statements | H302 |
Precautionary statements | P280-P305+P351+P338 |
Lersivirine(UK 453061) price
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
ChemScene | CS-1191 | Lersivirine 98.01% | 473921-12-9 | 5mg | $144 | 2021-12-16 | Buy |
ApexBio Technology | A3548 | Lersivirine | 473921-12-9 | 10mg | $186 | 2021-12-16 | Buy |
ChemScene | CS-1191 | Lersivirine 98.01% | 473921-12-9 | 10mg | $240 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | API0006072 | UK-453061 95.00% | 473921-12-9 | 5MG | $298.1 | 2021-12-16 | Buy |
AK Scientific | 3776AH | Lersivirine | 473921-12-9 | 5mg | $353 | 2021-12-16 | Buy |
Lersivirine(UK 453061) Chemical Properties,Uses,Production
Definition
ChEBI: Lersivirine is an aromatic ether.
Biological Activity
lersivirine (uk-453061) is a next-generation non-nucleoside reverse transcriptase inhibitor (nnrti)for human immunodeficincy virus (hiv) infection with ic50 value of 119 nm [1].hiv is a retro virus that causes hiv infection and acquired immunodeficiency syndrome (aids). it may infect vital cells of human immune system such as helper t cells and dendritic cells. hiv transcriptase plays an important role in the infection process. hiv carries a reverse transcriptase which can transcript single-stranded virus rna into double-stranded dna. when the virus anchor to the target cell surface, the reverse transcriptase will be injected into host cell, there it may complete the transcription. and the transcribed dna is able to integrate into host genome to complete infection and viral replication.lersivirine (uk-453061) is a nnrti with a unique resistance profile that exhibits potent antiretroviral activity against wild-type hiv and clinically relevant nnrti-resistant strains. when lersivirine was tested with a panel of isolated wild-type and drug-resistant hiv reverse transcriptase, it exhibited excellent inhibitory activity, which confirmed the high potency of it as the next-generation anti-hiv nnrti. the compound also has good aqueous solubility and formulation characteristics which enable further in vivo evaluation [2].mated crl:cd1 mice were administered 0, 150, 350, and 500 mg/kg lersivirine once daily by oral gavage on gestation days 6 to 17, followed by cesarean section on gestation day 18. the first 2 days of dosing for the high-dose group were done at 250 mg/kg to allow induction of hepatic metabolizing enzymes, after which the dose was increased to 500 mg/kg/day. exposure of lersivirine did not cause any increases in external, visceral, or skeletal malformation, which demonstrated lersivirine is not teratogenic in mice [3].
target
reverse transcriptase
References
[1] mowbray c e et al. , pyrazole nnrtis 4: selection of uk-453,061 (lersivirine) as a development candidate. bioorg med chem lett. 2009, 19(20):5857-60.
[2] davis j et al. , the effect of lersivirine, a next-generation nnrti, on the pharmacokinetics of midazolam and oral contraceptives in healthy subjects. eur j clin pharmacol. 2012, 68(11):1567-1572.
[3] cappon g d et al. , developmental toxicity study of lersivirine in mice. birth defects res b dev reprod toxicol. 2012, 95(3):225-30.
Lersivirine(UK 453061) Preparation Products And Raw materials
Raw materials
Preparation Products
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 32480 | 60 |
CONIER CHEM AND PHARMA LIMITED | +8618523575427 | sales@conier.com | China | 47465 | 58 |
career henan chemical co | +86-0371-86658258 15093356674; | factory@coreychem.com | China | 29826 | 58 |
Zhejiang J&C Biological Technology Co.,Limited | +1-2135480471 +1-2135480471 | sales@sarms4muscle.com | China | 10523 | 58 |
InvivoChem | +1-708-310-1919 +1-13798911105 | sales@invivochem.cn | United States | 6393 | 58 |
LEAP CHEM CO., LTD. | +86-852-30606658 | market18@leapchem.com | China | 24738 | 58 |
Hangzhou MolCore BioPharmatech Co.,Ltd. | +86-057181025280; +8617767106207 | sales@molcore.com | China | 49739 | 58 |
Nantong HI-FUTURE Biology Co., Ltd. | +undefined18051384581 | sales@chemhifuture.com | China | 3136 | 58 |
TargetMol Chemicals Inc. | +1-781-999-5354 | support@targetmol.com | United States | 19973 | 58 |
Amadis Chemical Company Limited | 571-89925085 | sales@amadischem.com | China | 131981 | 58 |
View Lastest Price from Lersivirine(UK 453061) manufacturers
Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
---|---|---|---|---|---|---|---|---|
2019-12-26 | 3-Cyano-5-[[3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl]oxy]benzonitrile
473921-12-9
|
US $1.00 / g | 1g | ≥98% | g/kg/Ton | Career Henan Chemical Co |
- 3-Cyano-5-[[3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl]oxy]benzonitrile
473921-12-9
- US $1.00 / g
- ≥98%
- Career Henan Chemical Co